Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Akazawa

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Pharmacoepidemiology and Drug Safety|July 29, 2017
Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective studyNobutaka Kitamura, Kuniaki Seyama, Yoshikazu Inoue, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 28, 2021
Novel electrocardiographic criteria for short QT syndrome in children and adolescentsHiroshi Suzuki, Minoru Horie, Junichi Ozawa, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 4, 2017
Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitisHarumi Gomi, Tadahiro Takada, Tsann-Long Hwang, et al.
Anticancer Research|August 2, 2019
Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 TreatmentMitsuhiro Hayashi, Kyoko Nakazawa, Yoshie Hasegawa, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 20, 2017
Descriptive review of acute cholecystitis: Japan-Taiwan collaborative epidemiological studyMasamichi Yokoe, Tadahiro Takada, Tsann-Long Hwang, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 19, 2017
Validation of TG13 severity grading in acute cholecystitis: Japan-Taiwan collaborative study for acute cholecystitisMasamichi Yokoe, Tadahiro Takada, Tsann-Long Hwang, et al.
Anticancer Research|July 3, 2017
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian CancerKohei Miyata, Fusanori Yotsumoto, Satoshi Fukagawa, et al.
The Lancet. Gastroenterology & Hepatology|April 11, 2018
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trialMasatoshi Kudo, Kazuomi Ueshima, Osamu Yokosuka, et al.
Genome Medicine|November 2, 2017
Actionable gene-based classification toward precision medicine in gastric cancerHiroshi Ichikawa, Masayuki Nagahashi, Yoshifumi Shimada, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2010
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosisRyushi Tazawa, Bruce C Trapnell, Yoshikazu Inoue, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Pharmacoepidemiology and Drug Safety|July 29, 2017
Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective studyNobutaka Kitamura, Kuniaki Seyama, Yoshikazu Inoue, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 28, 2021
Novel electrocardiographic criteria for short QT syndrome in children and adolescentsHiroshi Suzuki, Minoru Horie, Junichi Ozawa, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 4, 2017
Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitisHarumi Gomi, Tadahiro Takada, Tsann-Long Hwang, et al.
Anticancer Research|August 2, 2019
Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 TreatmentMitsuhiro Hayashi, Kyoko Nakazawa, Yoshie Hasegawa, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 20, 2017
Descriptive review of acute cholecystitis: Japan-Taiwan collaborative epidemiological studyMasamichi Yokoe, Tadahiro Takada, Tsann-Long Hwang, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 19, 2017
Validation of TG13 severity grading in acute cholecystitis: Japan-Taiwan collaborative study for acute cholecystitisMasamichi Yokoe, Tadahiro Takada, Tsann-Long Hwang, et al.
Anticancer Research|July 3, 2017
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian CancerKohei Miyata, Fusanori Yotsumoto, Satoshi Fukagawa, et al.
The Lancet. Gastroenterology & Hepatology|April 11, 2018
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trialMasatoshi Kudo, Kazuomi Ueshima, Osamu Yokosuka, et al.
Genome Medicine|November 2, 2017
Actionable gene-based classification toward precision medicine in gastric cancerHiroshi Ichikawa, Masayuki Nagahashi, Yoshifumi Shimada, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2010
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosisRyushi Tazawa, Bruce C Trapnell, Yoshikazu Inoue, et al.
Pageof 13